A phase 1 clinical trial is now open for enrollment to patients with high-grade neuroendocrine tumors to receive treatment ...

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

A clinical trial for patients with high-grade neuroendocrine tumors is now ... SVV doesn't infect normal cells. It grows inside tumor cells and busts them open. When the tumor cells burst, they ...

In January 2025, the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Neuroendocrine and Adrenal Tumors were updated to include cabozantinib as a category 1 ...

FDA approves Exelixis' Cabometyx for advanced neuroendocrine tumors before the April 3 action date, expanding its previous five approvals. Phase 3 trial data shows Cabometyx plus Opdivo sustains ...